Phenomenology and Classification of Dystonia: a Consensus Update
Overview
Authors
Affiliations
This report describes the consensus outcome of an international panel consisting of investigators with years of experience in this field that reviewed the definition and classification of dystonia. Agreement was obtained based on a consensus development methodology during 3 in-person meetings and manuscript review by mail. Dystonia is defined as a movement disorder characterized by sustained or intermittent muscle contractions causing abnormal, often repetitive, movements, postures, or both. Dystonic movements are typically patterned and twisting, and may be tremulous. Dystonia is often initiated or worsened by voluntary action and associated with overflow muscle activation. Dystonia is classified along 2 axes: clinical characteristics, including age at onset, body distribution, temporal pattern and associated features (additional movement disorders or neurological features); and etiology, which includes nervous system pathology and inheritance. The clinical characteristics fall into several specific dystonia syndromes that help to guide diagnosis and treatment. We provide here a new general definition of dystonia and propose a new classification. We encourage clinicians and researchers to use these innovative definition and classification and test them in the clinical setting on a variety of patients with dystonia. © 2013 Movement Disorder Society.
Kaymak A, Romito L, Colucci F, Andreasi N, Telese R, Rinaldo S Eur J Neurol. 2025; 32(3):e70098.
PMID: 40062447 PMC: 11891763. DOI: 10.1111/ene.70098.
Patient Burden in Dystonia Diagnosis and Botulinum Toxin Treatment: A Nationwide Survey in Turkey.
Yilmaz R, Oksuz N, Ceylan M, Samanci B, Acarer A, Durmaz Celik N Brain Behav. 2025; 15(3):e70325.
PMID: 40021839 PMC: 11870789. DOI: 10.1002/brb3.70325.
Editorial: Role of neuroimaging in the diagnosis and treatment of rare diseases.
Shazeeb M, Acosta M, Tifft C Front Neuroimaging. 2025; 4:1566484.
PMID: 40017823 PMC: 11865246. DOI: 10.3389/fnimg.2025.1566484.
Elshebawy H, Ramzy G, Salama M, El-Jaafary S Acta Neurol Belg. 2025; .
PMID: 39992580 DOI: 10.1007/s13760-025-02742-x.
Cif L, Cif L, Demailly D, Demailly D, Lin J, Lin J ArXiv. 2025; .
PMID: 39990802 PMC: 11844621.